Simi Valley, CA, United States of America

Thomas Seewoester

USPTO Granted Patents = 9 

Average Co-Inventor Count = 9.0

ph-index = 8

Forward Citations = 301(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Thomas Seewoester: Innovator in Cell Culture Technology

Introduction

Thomas Seewoester is a notable inventor based in Simi Valley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of cell culture technologies. With a total of 9 patents to his name, Seewoester has focused on improving methods for producing recombinant proteins in mammalian cell cultures.

Latest Patents

Among his latest patents, Seewoester has developed a modified serum-free cell culture medium. This invention describes improved methods and compositions for producing recombinant proteins, such as antibodies, in mammalian cell culture. Additionally, it provides enhanced cell culture media, including production media, feed solutions, and combination feeds, aimed at improving protein productivity in mammalian cell culture. Another significant patent involves methods of producing adalimumab, which also focuses on improving the production of recombinant proteins in similar settings.

Career Highlights

Throughout his career, Thomas Seewoester has worked with prominent companies in the biotechnology sector, including AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has allowed him to refine his expertise in cell culture technologies and contribute to advancements in the field.

Collaborations

Seewoester has collaborated with several professionals in his field, including Itzcoatl A Pla and John C Fann. These collaborations have likely enriched his work and led to innovative solutions in biotechnology.

Conclusion

Thomas Seewoester's contributions to cell culture technology and his impressive portfolio of patents highlight his role as an influential inventor in the biotechnology industry. His work continues to impact the production of recombinant proteins, paving the way for advancements in medical and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…